Robert Flath is a seasoned finance executive currently serving as Vice President of Finance & Strategy at MindMed since 2025. They previously held leadership roles, including Senior Director of Finance at Bristol Myers Squibb and Turning Point Therapeutics, which was acquired by Bristol Myers Squibb in 2022. Their experience spans several organizations, including Regulus Therapeutics as Senior Manager II of FP&A and Crinetics Pharmaceuticals as Director of Finance. Robert's educational background includes both a Bachelor's and a Master's degree in Finance from the University of Arizona.
This person is not in the org chart
This person is not in any teams
This person is not in any offices